Rucaparib Camsylate Suppliers & Bulk Manufacturers

Available Forms: Oral tablets

Available Strengths: 200 mg, 250 mg, 300 mg

Reference Brands: Rubraca® (EU & US)

Category: Oncology Cancer Care

Rucaparib Camsylate is available in Oral tablets and strengths such as 200 mg, 250 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Rucaparib Camsylate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Rucaparib Camsylate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Rucaparib Camsylate is an innovative PARP inhibitor used in the treatment of ovarian, fallopian tube, and peritoneal cancers. This targeted therapy is especially effective in cancers with BRCA mutations, as it disrupts DNA repair mechanisms in cancer cells, leading to their destruction. Available under the brand name Rubraca®, it is offered in 200 mg, 250 mg, and 300 mg oral tablet strengths. Manufactured under GMP-certified conditions, Rucaparib is a trusted solution in oncology care. Ideal for US and EU pharmaceutical distributors and wholesalers, it provides an advanced treatment option in precision medicine for cancer patients.